Outcome of Board Meeting of Financial Results for Quarter ended June 30, 2026

Shalby/SE/2026‐27/36 August 12, 2026 The Listing Department Corporate Service Department National Stock Exchange of India Ltd BSE Limited Mumbai 400 051. Mumbai 400 001. Scrip Code : SHALBY Scrip Code: 540797 Through : https://neaps.nseindia.com/NEWLISTINGCORP/ Through : http://listing.bseindia.com Sub: Outcome of the Board Meeting of the Company Dear Sir / Madam, In continuation of our intimation letter no. Shalby/SE/2026‐27/28 dated July 15, 2026, letter no. Shalby/SE/2026‐27/32 dated July 27, 2026 and pursuant to Regulation 30, 33 and other applicable provisions of LODR Regulations, as amended from time to time, we would like to inform you that the Board of Directors of Shalby Limited (the "Company") at its meeting held today, i.e. Wednesday, August 12, 2026 which commenced at 5:13 p.m. and concluded at 6.15 p.m. has inter alia transacted the following businesses: 1. Unaudited Financial Results Considered and approved Unaudited Standalone and Consolidated Financial results for the quarter ended June 30, 2026, together with the Limited Review Report issued by the Statutory Auditors of the Company thereon. The said financial results along with Limited Review Report are attached herewith as Annexure – A and are available on the website of the Company at www.shalby.org 2. Cost Audit Report Considered and approved Cost Audit Report on the cost records of the Company for the financial year ended March 31, 2026 issued by M/s. Borad Sanjay B & Associates, Cost Accountants. 3. Appointment of Whole‐Time Director Considered and approved appointment of Mr. Shanay Vikram Shah (DIN: 02726541) as an Additional Director designated as Whole‐Time Director for a term of five consecutive years with effect from August 12, 2026, pursuant to the recommendation of the Nomination and Remuneration Committee, prior approval of Audit Committee and, subject to the approval of shareholders at the ensuing Annual General Meeting. He shall also be designated as a Key Managerial Personnel of the Company as per Section 203 of the Companies Act, 2013. Mr. Shanay Vikram Shah is not disqualified or debarred from holding the office of Director pursuant to any order issued by Securities and Exchange Board of India or any other such authority, and declaration to this effect has been obtained pursuant to BSE Circular No. LIST/COMP /14/2018‐19 dated June 20, 2018, and NSE Circular No. NSE/ CML/2018/24 dated June 20, 2018. Mr. Shanay Vikram Shah, shall hold office as an Additional Director designated as Whole‐ Time Director until the conclusion of the ensuing Annual General Meeting. The matter of his appointment as Whole‐Time Director for a term of five consecutive years with effect from August 12, 2026 is being placed before the shareholders for approval at the ensuing 22nd Annual General Meeting scheduled to be held on Thursday, September 10, 2026. The details relating to appointment of Director as required under Regulation 30 of the SEBI (LODR) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CFDPoD‐ 1/P/CIR/2023/123 dated July 13, 2023 is enclosed as Annexure – B. 4. Appointment of Internal Auditors Considered and approved appointment of M/s. PricewaterhouseCoopers Services LLP, Chartered Accountants, as Internal Auditors of the Company for the financial year 2026‐27, as recommended by Audit Committee of the Company. 5. Approval of Notice of 22nd Annual General Meeting Approved Notice for convening the 22nd Annual General Meeting of the Members of the Company, scheduled to be held on Thursday, September 10, 2026 at 4:00 p.m. IST. 6. Acquisition of remaining 0.67% shares by Shalby Medtech Limited (Earlier known as Mars Medical Devices Limited) in Shalby Global Technologies Pte. Ltd. The Board of Directors took note of the acquisition of 10,000 equity shares representing 0.67% equity share capital of Shalby Global Technologies Pte. Ltd., Singapore (Step‐down subsidiary of the Company) by Shalby Medtech Limited (Earlier known as Mars Medical Devices Limited ) (Wholly‐owned subsidiary of the Company) from Dr. Vikram Shah and Mr. Shanay Shah. Post‐acquisition, Shalby Global Technologies Pte. Ltd. is now a wholly‐owned subsidiary of Shalby Medtech Limited, effective from August 12, 2026. The details as required under Regulation 30 of the SEBI (LODR) Regulations, 2015 read with read with SEBI Circular CIR/CFD/CMD/4/2015 dated 09 September, 2015 are enclosed herewith as Annexure – C. We request to take the same on your records. Thanking you, For Shalby Limited Tushar Shah Vice President & Company Secretary Mem. No. F7216 Encl.: As above Annexure – B Details under Regulation 30 of the SEBI (listing Obligations and Disclosure Requirements) Regulations. 2015 read with SEBI Circular CIR/CFD/CMD/4/2015 dated 09 September, 2015 Sr. Particulars Disclosures 1 Reason for change viz. Appointment of Mr. Shanay Vikram Shah (DIN: 02726541) as an appointment, Additional Director designated as Whole‐Time Director for a term of resignation, removal, five consecutive years, with effect from August 12, 2026, subject to death or otherwise the approval of Shareholders at the ensuing Annual General Meeting 2 Date of appointment / Appointment for a term of five consecutive years, with effect from cessation (as applicable) August 12, 2026. & term of appointment 3 Brief profile (in case of Mr. Shanay Vikram Shah, aged 35 years, holds a Bachelor’s degree in appointment) Science with Honors in Accounting and Finance from the University of Warwick, United Kingdom, and a Master’s degree in International Health Management from Imperial College London, United Kingdom. He is also a Chartered Financial Analyst (CFA). Mr. Shanay Vikram Shah is one of the Promoters of the Company and is a relative of Dr. Vikram I. Shah (DIN: 00011653), Promoter, Chairman and Managing Director of the Company and has been associated with the Company since October 5, 2013, with over a decade of experience in the healthcare industry, including but not limited to oversight of the Company’s business including international business, strategy, financial operations, Human Resource, and investor relations. He was earlier appointed as President of the Company to hold an office or place of profit for a term of five years with effect from October 5, 2024. He is a key member of the Youth Presidents’ Organization (YPO) and is associated with industry chambers including CII, ICC, FICCI and ASSOCHAM. 4 Disclosure of Mr. Shanay Vikram Shah is related to Dr. Vikram Shah (DIN: relationships between 00011653), Promoter, Chairman and Managing Director of the directors (in case of Company, being his son. appointment of a director) Mr. Shanay Vikram Shah (DIN: 02726541) is not debarred from holding of office of Director pursuant to any order issued by Securities and Exchange Board of India or any other such authority. Annexure – C Details under Regulation 30 of the SEBI (listing Obligations and Disclosure Requirements) Regulations. 2015 read with SEBI Circular CIR/CFD/CMD/4/2015 dated 09 September, 2015 Sr. No. Particulars Details 1 Name of Target Entity Shalby Global Technologies Pte. Ltd., Step‐down subsidiary of the Company (“SGTPL”) Shalby Medtech Limited (Earlier known as Mars Medical Devices Limited) (Wholly‐owned subsidiary) has acquired 10,000 equity shares representing 0.67% equity share capital of SGTPL from Dr. Vikram Shah and Mr. Shanay Shah. Details in brief such as size, Turnover Paid up Share Capital: etc.; Paid‐up Equity Share Capital : 14,89,000 Equity Shares of SGD 1 each Paid‐up Preference Share Capital 4,00,000 Preference Shares of SGD 1 each. Turnover for FY 2025‐26: SGD 9,11,671 2 Whether the acquisition would fall The transaction falls within related party transaction. within related party transaction(s) The shares have been acquired from Dr. Vikram Shah and and whether the Mr. Shanay Shah, who were the existing shareholders of promoter/promoter group/group SGTPL. companies have any interest in the entity being acquired? If yes, [Showing first 8,000 characters — download PDF for full document]